ATE184017T1 - Leukinferon zubereitung - Google Patents

Leukinferon zubereitung

Info

Publication number: ATE184017T1
Authority: AT; Austria
Prior art keywords: composition; transal; complex; pct; prepared
Prior art date: 1992-09-22

Application number

AT93915614T

Other languages

English (en)

Inventor

P Vladimir Kuznetsov

Original Assignee

Intelcor Biotech Entpr Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-09-22

Filing date

1993-09-20

Publication date

1999-09-15

1993-09-20 Application filed by Intelcor Biotech Entpr Inc filed Critical Intelcor Biotech Entpr Inc

1999-09-15 Application granted granted Critical

1999-09-15 Publication of ATE184017T1 publication Critical patent/ATE184017T1/de

Links

108010091992 leukinferon Proteins 0.000 title 1
239000008346 aqueous phase Substances 0.000 abstract 4
239000000137 peptide hydrolase inhibitor Substances 0.000 abstract 4
102000004169 proteins and genes Human genes 0.000 abstract 4
108090000623 proteins and genes Proteins 0.000 abstract 4
238000005349 anion exchange Methods 0.000 abstract 3
229940042399 direct acting antivirals protease inhibitors Drugs 0.000 abstract 3
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 abstract 2
102000004127 Cytokines Human genes 0.000 abstract 2
108090000695 Cytokines Proteins 0.000 abstract 2
239000002609 medium Substances 0.000 abstract 2
101710112984 20 kDa protein Proteins 0.000 abstract 1
101710134681 40 kDa protein Proteins 0.000 abstract 1
102000009027 Albumins Human genes 0.000 abstract 1
108010088751 Albumins Proteins 0.000 abstract 1
102100033312 Alpha-2-macroglobulin Human genes 0.000 abstract 1
101710159910 Movement protein Proteins 0.000 abstract 1
239000002202 Polyethylene glycol Substances 0.000 abstract 1
108010015078 Pregnancy-Associated alpha 2-Macroglobulins Proteins 0.000 abstract 1
102000004338 Transferrin Human genes 0.000 abstract 1
108090000901 Transferrin Proteins 0.000 abstract 1
101710090398 Viral interleukin-10 homolog Proteins 0.000 abstract 1
241000700605 Viruses Species 0.000 abstract 1
229940019748 antifibrinolytic proteinase inhibitors Drugs 0.000 abstract 1
239000013522 chelant Substances 0.000 abstract 1
238000012258 culturing Methods 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
108010074605 gamma-Globulins Proteins 0.000 abstract 1
239000001963 growth medium Substances 0.000 abstract 1
238000009169 immunotherapy Methods 0.000 abstract 1
239000012535 impurity Substances 0.000 abstract 1
229920001223 polyethylene glycol Polymers 0.000 abstract 1
230000001376 precipitating effect Effects 0.000 abstract 1
239000012581 transferrin Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Zoology (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

AT93915614T 1992-09-22 1993-09-20 Leukinferon zubereitung ATE184017T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA002078805A CA2078805C (en)	1992-09-22	1992-09-22	Cytokine preparation

Publications (1)

Publication Number	Publication Date
ATE184017T1 true ATE184017T1 (de)	1999-09-15

Family

ID=4150435

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93915614T ATE184017T1 (de)	1992-09-22	1993-09-20	Leukinferon zubereitung

Country Status (8)

Country	Link
US (1)	US5563120A (de)
EP (1)	EP0625160B1 (de)
JP (1)	JPH07504202A (de)
AT (1)	ATE184017T1 (de)
AU (1)	AU4940493A (de)
CA (1)	CA2078805C (de)
DE (1)	DE69326233D1 (de)
WO (1)	WO1994006820A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6962700B1 (en)	2000-09-13	2005-11-08	Atopix Pharmaceuticals Corporation	Method of manufacturing immune globulin
WO2008043570A1 (en) *	2006-10-12	2008-04-17	Helmholtz Zentrum Für Infektionsforschung	Interferon type i supporting compounds
US10265388B2 (en)	2012-02-21	2019-04-23	Cytonics Corporation	Systems, compositions, and methods for transplantation
AU2014312249A1 (en) *	2013-08-28	2016-03-24	Cytonics Corporation	Systems, compositions, and methods for transplantation and treating conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU192254B (en) *	1983-12-13	1987-05-28	Egyt Gyogyszervegyeszeti Gyar	Process for producing human leucocite and human gamma interferons in consecutive steps
SU1697828A1 (ru) *	1988-04-04	1991-12-15	Тбилисский Государственный Медицинский Институт	Способ лечени острого вирусного гепатита В.

1992
- 1992-09-22 CA CA002078805A patent/CA2078805C/en not_active Expired - Fee Related
1993
- 1993-09-20 EP EP93915614A patent/EP0625160B1/de not_active Expired - Lifetime
- 1993-09-20 JP JP5517814A patent/JPH07504202A/ja active Pending
- 1993-09-20 US US08/244,401 patent/US5563120A/en not_active Expired - Fee Related
- 1993-09-20 WO PCT/CA1993/000381 patent/WO1994006820A1/en not_active Ceased
- 1993-09-20 AT AT93915614T patent/ATE184017T1/de not_active IP Right Cessation
- 1993-09-20 AU AU49404/93A patent/AU4940493A/en not_active Abandoned
- 1993-09-20 DE DE69326233T patent/DE69326233D1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
US5563120A (en)	1996-10-08
WO1994006820A1 (en)	1994-03-31
EP0625160B1 (de)	1999-09-01
DE69326233D1 (de)	1999-10-07
CA2078805A1 (en)	1994-03-23
CA2078805C (en)	1997-02-25
EP0625160A1 (de)	1994-11-23
AU4940493A (en)	1994-04-12
JPH07504202A (ja)	1995-05-11

Similar Documents

Publication	Publication Date	Title
Trinchieri et al.	1978	Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation.
Villada et al.	1990	Toxic epidermal necrolysis after bone marrow transplantation: study of nine cases
US4188318A (en)	1980-02-12	Simplified method for preparation of high yield, high purity Factor VIII concentrate
JP2644946B2 (ja)	1997-08-25	ＩｇＧ− モノクロナール抗体の精製方法及びその使用方法
US6893639B2 (en)	2005-05-17	Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates
JPS6136228A (ja)	1986-02-20	肝炎表面抗原の精製方法
JPS58159417A (ja)	1983-09-21	均一なヒトのインタ−フエロン及びその製造方法
CA1054052A (en)	1979-05-08	Simplified method for preparation of high yield, high purity factor viii concentrate
ATE184017T1 (de)	1999-09-15	Leukinferon zubereitung
CA2314150C (en)	2001-10-23	Recovery of functional human leukocytes from recycled filters
Kalyanaraman et al.	1984	Immunological characterization of the low molecular weight gag gene proteins p19 and p15 of human T-cell leukemia-lymphoma virus (HTLV) and demonstration of human natural antibodies to them
JPS6261040B2 (de)	1987-12-18
JPS59135892A (ja)	1984-08-04	シグナルアミノ酸配列をコードするｄｎａ
Strander	1969	Production of interferon in serum-free human leukocyte suspensions
JPH01281097A (ja)	1989-11-13	ヒトインターフェロンの製造方法
JPS57179123A (en)	1982-11-04	Purification of number viii factor-containing aqueous solution
Sato et al.	1982	Spontaneous interferon production and growth of lymphoblastoid cells in serum-free medium
Ikenaka et al.	1965	A method for the isolation of pyroglutaminyl peptides from glycoproteins.
ATE477267T1 (de)	2010-08-15	Methode zur reinigung von proteinen
Whitman JR et al.	1981	Purification of human lymphoblastoid cell-derived interferon-alpha by controlled-pore glass bead adsorption chromatography and molecular sieving
JPH07173190A (ja)	1995-07-11	血漿蛋白の分画方法
JPS641118B2 (de)	1989-01-10
Fowell et al.	1948	The fractionation by alcohol of equine antitoxic plasma
KR0137153B1 (ko)	1998-04-25	C형 간염 바이러스에 대한 인체면역 조절기능을 가진 펩타이드
KR0166425B1 (ko)	1999-01-15	한탄 바이러스에 대한 인체 면역조절기능을 가진 펩타이드

Legal Events

Date	Code	Title	Description
2000-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties